Işıldar, B. Et Al. 2023. Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS. ISCT2023 , (Paris, France), 3-4.

Işıldar, B., Erçin, M., Oktayoğlu, S., & Koyutürk, M., (2023). Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS . ISCT2023 (pp.3-4). Paris, France

Işıldar, Başak Et Al. "Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS," ISCT2023, Paris, France, 2023

Işıldar, Başak Et Al. "Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS." ISCT2023 , Paris, France, pp.3-4, 2023

Işıldar, B. Et Al. (2023) . "Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS." ISCT2023 , Paris, France, pp.3-4.

@conferencepaper{conferencepaper, author={Başak Işıldar Et Al. }, title={Mesenchymal Stem/Stromal Cells: THERAPEUTIC EFFECTS OF CONDITIONED MEDIUM FROM HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS WITH/WITHOUT DEFEROXAMINE-PRECONDITIONING ON THE SEVERE TYPE 1 DIABETES MODEL IN RATS}, congress name={ISCT2023}, city={Paris}, country={France}, year={2023}, pages={3-4} }